Navigation Links
Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer
Date:4/29/2009

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- The recent announcement of the REDUCE trial results at the American Urological Association annual meeting in Chicago brings optimism to the prostate cancer community as dutasteride (Avodart), a drug used to treat benign prostatic hyperplasia, has shown to lower by 23 percent the risk of prostate cancer in men with an increased risk of the disease.

Men's Health Network looks forward to this becoming an additional tool in the fight against prostate cancer.

The REDUCE trial is a placebo-controlled study that evaluates whether dutasteride decreases the risk of biopsy-detectable prostate cancer.

As this disease continues to strike one in six American men, with African American men having an incidence rate up to 60% higher than white men, it is important that patients and physicians engage in a meaningful conversation about prostate cancer, an individual's risk of getting the disease, and the value of early detection and prevention.

Scott Williams, Vice President, Men's Health Network commented, "We continually stress the importance for men to receive a baseline Prostate Specific Antigen or PSA and physical exam of the prostate at age 40 and to engage in a continual dialogue with their physician about their individual risk and need for annual prostate exams. It could mean the difference between living with the disease or dying from the disease."

PSA is currently the most effective tool physicians and patients have to detect a disease that kills an estimated 28,000 men a year in the US.

In addition to the approximately 200,000 men who are diagnosed with prostate cancer each year, we must remember that the disease can have a devastating effect on entire families and communities. Spouses, significant others, and children are often emotionally, financially, and physically strained and the diagnosis reaches b
'/>"/>

SOURCE Men's Health Network
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Another Study Links Fluoride to Bone Cancer
2. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
3. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
4. Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
5. An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
6. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
7. InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
10. Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
11. Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 02, 2015 Research and ... of the "Global Neurodegenerative Diseases Market 2015-2019" ... global neurodegenerative diseases market to grow at a ... This report covers the present scenario and ... market for the period 2015-2019. To calculate the ...
(Date:6/3/2015)... PillPack, the pharmacy that simplifies medication management, today announced ... led by CRV with participation from Accel Partners, Atlas ... be used to fuel growth, accelerate the hiring of ... markets. "In the last two years, we,ve ... folks absolutely love," says TJ Parker, PharmD, CEO of ...
(Date:6/3/2015)... Calif. , June 3, 2015  Armetheon, ... molecule drugs for cardiovascular diseases, today announced that ... been appointed Chief Executive Officer, effective immediately. Dr. ... in global, high-growth enterprises, with a successful track ... of human health. With expertise that includes the ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
(Date:6/3/2015)... June 03, 2015 Hexagon Geospatial is ... winner of its 2015 U.S. Education Challenge, which showcases ... a college or university in the U.S. , ... focused on Remote Sensing and Civil Engineering at the ... “Pavement Surface Cracks Detection and Assessment Based on Hyper-spatial ...
(Date:6/3/2015)... 03, 2015 Loma Linda University Health ... with San Gorgonio Memorial Hospital (SGMH). The SGMH board ... May 28. , “Loma Linda University Health has been ... Heinrich, chief executive officer, Loma Linda University Medical Center. ... our services to this community.” , Under the ...
(Date:6/3/2015)... NJ (PRWEB) June 03, 2015 ... across platforms and devices, announced today that it has ... in Collaboration and Content. The company was honored among ... demonstrating excellence in innovation and implementation of customer solutions ... Microsoft Partner of the Year Awards – including the ...
(Date:6/3/2015)... Baltimore, MD (PRWEB) June 03, 2015 ... firm that transforms businesses with technology, announced today that ... Officer. Mr. Dodge joins The Canton Group ... on years of successful customer engagements. , Tim is ... marketing functions for a variety of technology companies. Before ...
(Date:6/3/2015)... June 03, 2015 The National Resident ... that Maria C. Savoia, M.D., Dean of Medical Education at ... will become Chair on July 1. , “It ... the National Resident Matching Program,” said Dr. Savoia. “NRMP’s ... for matching medical students with training programs, and I welcome ...
Breaking Medicine News(10 mins):Health News:Hexagon Geospatial Announces U.S. Education Challenge Winner at HxGN Live 2015 2Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 3Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4
... The former director of information technology for a ... guilty plea to intruding into her former employer,s computer ... A. Breuer, acting U.S. Attorney Tim Johnson and FBI ... a hearing before U.S. District Judge David Hittner, Danielle ...
... Aranesp, experts say, , , THURSDAY, April 30 (HealthDay News) ... such as Procrit and Aranesp, often used by cancer ... of death and serious adverse events such as blood ... also been associated in prior studies with increased risk ...
... Zealand, April 30 As the world mourns the deaths ... outside of Mexican soil, the World Health Organization has raised ... being confirmed in California, Texas, New York, Maine and Massachusetts, ... New Zealand, people all over the globe are beginning to ...
... As an expectant mother, her first official Mother,s Day doesn,t ... Here are four unique ideas to make this Mother,s Day unforgettable ... rest, this can be a vexing time. She knows it ... off her feet, but she is still very aware that laundry ...
... A new poll by the Pew Research Center,s Forum ... Catholics who have heard about the issue support President ... divisions exist between the most-observant Catholics and those who ... over their assessment of Obama,s job performance.Conducted from April ...
... April 30 Cadence ... company focused on in-licensing, developing and commercializing proprietary product ... announced that it will release its first quarter ended ... on Thursday, May 7, 2009. Cadence management will host ...
Cached Medicine News:Health News:Computer Administrator Pleads Guilty to Hacking Former Employer's Computer System 2Health News:Anemia Drugs May Raise Death Risk in Cancer Patients 2Health News:Anemia Drugs May Raise Death Risk in Cancer Patients 3Health News:Anemia Drugs May Raise Death Risk in Cancer Patients 4Health News:All Natural System Sweeps Swine Flu Out with the Trash 2Health News:Four Unique Gifts for Expectant Moms Includes New Technology That Enhances Pre-Natal Bonding 2Health News:New Poll on Obama, Catholics and the Notre Dame Commencement Finds Deep Divisions Among Catholics 2
... Flextend lead is a ... with an extendable/retractable active-fixation ... design offers various lead ... implantation in the atrium ...
... leads are implantable bipolar extendable/retractable screw-in ... either the atrium or the ventricle. ... be extended or retracted by turning ... contains an anti-chattering mechanism for steady ...
Used with permanent pacing leads....
... Tupos LA, the only ICD system in ... the first implant for the treatment of ... a lasting improvement of their hemodynamics and ... LA uses biatrial stimulation to effectively suppress ...
Medicine Products: